Hong Zhao

Hong Zhao

Auto-generated profile, based on publicly available information

Hong Zhao

Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310029, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2022 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
HZHong Zhao
Hong Zhao
JYJie Yu
Jie Yu
GWGaoqi Weng
Gaoqi Weng
JYJiahui Yu
Jiahui Yu
EWErcheng Wang
Ercheng Wang
YKYu Kang
Yu Kang
The structural dynamics of the target-recognition-domain loop and its role in regulating DNMT3A activity are investigated through MD simulations, which would arouse more interest in the rational design of novel DNMT3A inhibitors targeting the region.

23 May 2023 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
ZZZehao Zhang
Zehao Zhang
YZYun Zhou
Yun Zhou
HZHong Zhao
Hong Zhao
YWYihang Wu
Yihang Wu
LSLianli Sun
Lianli Sun
The chemoselectivity of perakine reductase (PR) was engineered through rational design.

29 January 2022 in Materials Letters
Verified
Journal Article
Closed access
XGXin Guo
Xin Guo
DHDajian Huang
Dajian Huang
WBWenxia Bai
Wenxia Bai
HZHong Zhao
Hong Zhao
COChengwei Ouyang
Chengwei Ouyang
LFLibang Feng
Libang Feng

10 July 2026 in Science Advances
Verified
Journal Article
Open access
QWQingang Wu
Qingang Wu
RSRongkai Shi
Rongkai Shi
LXLiwei Xiao
Liwei Xiao
XHXuxiao He
Xuxiao He
ZCZhuoneng Chen
Zhuoneng Chen
ZLZhimin Lu
Zhimin Lu
Toll-like receptor (TLR) signaling is critical for innate immune system. However, whether it is directly modulated by microbiota-derived metabolites remains unclear. Here, we show that the short-chain fatty acids (SCFAs) propionate and butyrate suppress TLR signaling by directly binding p38α MAP kinase, promoting its interaction with TAB1, thereby activating p38α via autophosphorylation. Activated p38α then phosphorylates TRAF3 at serine 85, inhibiting K63-linked polyubiquitylation of TRAF3 and disrupting TBK1-IRF3 activation, leading to reduced macrophage activation and intestinal inflammation. In ulcerative colitis patients, fecal levels of propionate and butyrate positively correlate with p38α activity and TRAF3 S85 phosphorylation, but inversely correlate with TBK1 activation, and cytokine levels. Notably, oral administration of propionate in three patients with ulcerative colitis markedly improved intestinal inflammation and clinical symptoms. These findings reveal p38α as a direct sensor for microbiota-derived SCFAs that suppress TLR signaling through nonmetabolic functions of propionate and butyrate, providing the first clinical evidence that propionate supplementation represents a practical dietary strategy for ulcerative colitis management.

31 March 2023
Verified
Other
Open access
JLJunbo Liang
Junbo Liang
HZHong Zhao
Hong Zhao
BDBill H. Diplas
Bill H. Diplas
SLSong Liu
Song Liu
JLJianmei Liu
Jianmei Liu
YJYuchen Jiao
Yuchen Jiao
Supplementary Figure S3. Validation of ATRX synthetic lethal candidates by RNAi.

31 March 2023
Verified
Other
Open access
JLJunbo Liang
Junbo Liang
HZHong Zhao
Hong Zhao
BDBill H. Diplas
Bill H. Diplas
SLSong Liu
Song Liu
JLJianmei Liu
Jianmei Liu
YJYuchen Jiao
Yuchen Jiao
Supplementary Figure S3. Validation of ATRX synthetic lethal candidates by RNAi.